Julie L. Gerberding - EVP, Chief Patient Officer at Merck & Co., Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Patient Officer
Issuer Symbol
MRK on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julie L. Gerberding since 03 Feb 2025

Holdings reported by Julie L. Gerberding for Merck & Co., Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48,712 $5,817,691 $119.43 24 Feb 2022 Direct
Stock Option (Right to Buy) 22,831 01 Nov 2021 Direct Common Stock

Transactions reported by Julie L. Gerberding for Merck & Co., Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.